The lab testing data company.

Hyperdrive is the lab testing data company. We aggregate de-identified testing data from pathology and genomics reference labs, resolve it to the ordering provider, link it to curated public data, and deliver it as commercial analytics and sales enablement for biopharma and diagnostics companies.

Biopharma and diagnostics companies. Biopharma teams use Hyperdrive to find the providers testing treatment-eligible patients and to see where biomarker testing falls short. Diagnostics companies use it to track testing and test adoption trends for forecasting and market sizing. Pathology and genomics labs take part as data partners in the Lab Data Network.

Proprietary data comes from the Lab Data Network, a select group of pathology and genomics reference laboratories that supply de-identified testing data directly: more than 6 million test orders and results and 3.8 million new patient cases a year, resolved to the ordering provider. It is linked to curated public data from CMS, Medicare, PECOS and public use files.

Voyager is Hyperdrive's sales enablement software, built on the same data. Teams use it to build targeted lists of hospitals, physician groups, laboratories and specialty providers, enrich them with verified contact detail, and work them as leads with notes, reports and sales routes, or export them to their CRM.

Analytics for biopharma and diagnostics teams, built on proprietary laboratory testing and biomarker data from the Hyperdrive Lab Data Network. They include HCP alerts, patient finding, testing gap analytics, test adoption trends, market landscaping and targeting, delivered as prospective weekly data with lookbacks or as custom analyses.

All aggregated data from the Lab Data Network is de-identified under the HIPAA Safe Harbor method or by Expert Determination before it is used in any Hyperdrive product.